SCHEMBL20182242

SCHEMBL20182242

CCC(/C(=C/Nc1ccccc1F)N=N)n1cc(C)c2c(Cl)ncnc21

nearest known ligand 0.30

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.30
NR2F2 P24468 1/20 0.30
KMT2A Q03164 1/20 0.30
ADK P55263 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20182248 0.89 LRRK2 (0.34)
SCHEMBL20182343 0.88 ADK (0.31) ADK
SCHEMBL20182234 0.79 EGFR (0.35)
SCHEMBL20182195 0.77 NTRK1 (0.33)
SCHEMBL20182255 0.77 SRC (0.39)
SCHEMBL20182197 0.76 CFTR (0.43)
SCHEMBL20182198 0.76 SRC (0.34)
SCHEMBL20181916 0.74 CFTR (0.39)
SCHEMBL20182194 0.74 EIF2AK3 (0.36)
SCHEMBL20182202 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed